Tag: Geron

December 4, 2018

5 Top NASDAQ Genetics Stocks Year-to-Date

As Q4 and 2018 come to a close, the Investing News Network profiles the five top genetics stocks on the...
December 4, 2018

Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients

Geron (Nasdaq:GERN) today announced that results from IMbark, a Phase 2 clinical trial of imetelstat treatment in Intermediate-2 or High-risk...
November 4, 2018

5 Top Weekly NASDAQ Biotech Stocks: Aptose Leads this Week

Aptose Biosciences, Trevena, Curis, Geron and Aveo Pharmaceuticals were last week's top gainers on the NASDAQ Biotechnology Index.
October 4, 2018

5 Top NASDAQ Genetics Stocks of Q3 2018

With Q3 2018 over, we've profiled the five top NASDAQ genetics stocks year-to-date. Here's a look at what they've been...
September 27, 2018

Geron Cancels Janssen Collaboration, Share Price Drops

Geron and Johnson & Johnson’s subsidiary, Janssen Biotech, have terminated their partnership on development of a drug for two different...
September 27, 2018

Geron Announces Discontinuation of Imetelstat Collaboration by Janssen

Geron (Nasdaq:GERN) today announced that Janssen Biotech has terminated the 2014 Collaboration and License Agreement (CLA) with the Company. Janssen...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.